Table 2.
Paediatric care |
Adult care |
||
---|---|---|---|
n (%) /median [IQR] | p value | ||
Prescribed ART at last follow-up | 200 (74%) | 228 (84%) | 0.001 |
CD4 count 12 months pre/post transfer (n = 204*) | 465 [288,668] | 460 [290,670] | 0.38 |
CD4 < 200 cells/mm3 at least once in 12 months pre/post transfer (n = 195*) | 41 (21%) | 45 (23%) | 0.39 |
Two consecutive VL >400 copies/mL or one VL>10,000 copies/mL in 12 months pre/post transfer for those on ART for at least 6 months (n = 131*) | 37 (28%) | 38 (29%) | 0.85 |
Two consecutive VL >400 copies/mL or one VL>10,000 copies/mL in 12 months pre/post transfer irrespective of ART status (n = 196*) | 92 (47%) | 102 (52%) | 0.12 |
IQR, interquartile range; ART, antiretroviral therapy*n = number with paediatric and adult care data.